Home › Companies › ALX ONCOLOGY HOLDINGS INC. › 2023-2024
Compiled from SEC Form N-PX filings and ALX ONCOLOGY HOLDINGS INC.’s Form 8-K, filed 2024-06-17 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Proxy season: 2023-2024
Explore ALX ONCOLOGY HOLDINGS INC. in the interactive database Compare manager voting policies
These tallies are ALX ONCOLOGY HOLDINGS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-06-17 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Corey Goodman, Ph.D. | 35,775,363 | -- | -- | 6,616,621 | 5,320,757 | Majority: yes |
| Elect Director: Jason Lettmann | 33,828,276 | -- | -- | 8,563,708 | 5,320,757 | Majority: yes |
| Elect Director: Sophia Randolph, Ph.D. | 28,671,086 | -- | -- | 13,720,898 | 5,320,757 | Majority: yes |
| Proposal 2: Advisory Vote on the Compensation of the Company's Named Executive Officers | 40,935,354 | 1,422,239 | 34,391 | -- | 5,320,757 | Majority: yes |
| Proposal 3: Ratification of the Appointment of Independent Registered Public Accounting Firm | 47,698,670 | 11,338 | 2,733 | -- | -- | Majority: yes |
Source: ALX ONCOLOGY HOLDINGS INC., Form 8-K, filed with the SEC on 2024-06-17 — read the filing on EDGAR.
Each item below shows how the 130 asset managers that disclosed a ALX ONCOLOGY HOLDINGS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 3 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
ALX ONCOLOGY HOLDINGS INC.’s own tally for this item (“Proposal 2: Advisory Vote on the Compensation of the Company's Named Executive Officers”): 40,935,354 for, 1,422,239 against, per its Form 8-K filed 2024-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 52,100,107 outstanding shares: 79% for, 3% against (81% of the company cast a for/against vote).
The 130 asset managers below cast 99.5% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 13,850,890 | 0 | 0 | 0 | For |
| venBio Partners LLC | 9,699,925 | 0 | 0 | 0 | For |
| Redmile Group, LLC | 4,326,509 | 0 | 0 | 0 | For |
| Vivo Capital, LLC | 4,219,429 | 0 | 0 | 0 | For |
| Vestal Point Capital, LP | 3,428,204 | 0 | 0 | 0 | For |
| Cormorant Asset Management, LP | 2,290,149 | 0 | 0 | 0 | For |
| ORBIMED ADVISORS LLC | 1,586,100 | 0 | 0 | 0 | For |
| MPM BioImpact LLC | 1,279,037 | 0 | 0 | 0 | For |
| Vanguard | 970,999 | 0 | 0 | 0 | For |
| BlackRock | 886,925 | 14,960 | 0 | 0 | For |
| Citadel | 705,257 | 0 | 0 | 0 | For |
| State Street | 494,344 | 25 | 0 | 0 | For |
| T. Rowe Price | 354,642 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 345,529 | 0 | 0 | 0 | For |
| Charles Schwab | 227,368 | 0 | 0 | 0 | For |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 184,409 | 0 | 0 | 0 | For |
| BANK OF HAWAII | 150,000 | 0 | 0 | 0 | For |
| Northern Trust | 147,826 | 35 | 0 | 0 | For |
| Aberdeen | 0 | 132,422 | 0 | 0 | Against |
| Federated Hermes | 118,149 | 1,409 | 0 | 0 | For |
| Wellington | 105,267 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 101,142 | 0 | 0 | 0 | For |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 92,200 | 0 | 0 | 0 | For |
| Goldman Sachs | 55,448 | 0 | 0 | 0 | For |
| Renaissance | 46,103 | 0 | 0 | 0 | For |
Showing the 25 largest of 130 asset managers. See all 130 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
ALX ONCOLOGY HOLDINGS INC.’s own tally for this item (“Proposal 3: Ratification of the Appointment of Independent Registered Public Accounting Firm”): 47,698,670 for, 11,338 against, per its Form 8-K filed 2024-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 52,100,107 outstanding shares: 92% for, 0.1% against (92% of the company cast a for/against vote).
The 44 asset managers below cast 99.9% of the shares they voted on this item FOR (8,916,774 for, 57 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 7,049,685 | 0 | 0 | 0 | For |
| Vanguard | 936,245 | 0 | 0 | 0 | For |
| BlackRock | 262,973 | 0 | 0 | 0 | For |
| T. Rowe Price | 121,933 | 0 | 0 | 0 | For |
| Charles Schwab | 113,684 | 0 | 0 | 0 | For |
| Aberdeen | 66,211 | 0 | 0 | 0 | For |
| Federated Hermes | 57,913 | 0 | 0 | 0 | For |
| Equitable | 43,999 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 43,344 | 0 | 0 | 0 | For |
| Northern Lights Fund Trust IV | 33,156 | 0 | 0 | 0 | For |
| John Hancock | 29,125 | 0 | 0 | 0 | For |
| Lincoln Financial | 28,155 | 0 | 0 | 0 | For |
| Northern Trust | 19,883 | 0 | 0 | 0 | For |
| Goldman Sachs | 13,815 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 11,377 | 0 | 0 | 0 | For |
| Pacific Life | 10,736 | 0 | 0 | 0 | For |
| Global X | 9,458 | 0 | 0 | 0 | For |
| AQR | 8,956 | 0 | 0 | 0 | For |
| Voya | 8,755 | 0 | 0 | 0 | For |
| American Century | 7,925 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 6,566 | 0 | 0 | 0 | For |
| EDBI Pte Ltd | 5,613 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 5,546 | 0 | 0 | 0 | For |
| Principal | 3,025 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 2,963 | 0 | 0 | 0 | For |
Showing the 25 largest of 44 asset managers. See all 44 in the interactive database.
Combines 3 wordings of this item as funds reported it.
84% Majority: yes · of votes cast
ALX ONCOLOGY HOLDINGS INC.’s own tally for this item (“Elect Director: Corey Goodman, Ph.D.”): 35,775,363 for, 6,616,621 withheld, per its Form 8-K filed 2024-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 52,100,107 outstanding shares: 69% for, 13% withheld (81% of the company cast a for/withheld vote).
The 42 asset managers below cast 100% of the shares they voted on this item FOR (8,343,089 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 7,038,419 | 0 | 11,266 | 0 | For |
| Vanguard | 936,245 | 0 | 0 | 0 | For |
| BlackRock | 0 | 0 | 262,973 | 0 | Abstain |
| T. Rowe Price | 121,933 | 0 | 0 | 0 | For |
| Charles Schwab | 113,684 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 0 | 66,211 | 0 | Abstain |
| Federated Hermes | 57,913 | 0 | 0 | 0 | For |
| Equitable | 480 | 0 | 43,519 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 43,344 | 0 | Abstain |
| John Hancock | 22,469 | 0 | 6,656 | 0 | For |
| Lincoln Financial | 18,200 | 0 | 9,955 | 0 | For |
| Northern Trust | 19,883 | 0 | 0 | 0 | For |
| Goldman Sachs | 0 | 0 | 13,815 | 0 | Abstain |
| Bridge Builder Trust | 0 | 0 | 11,377 | 0 | Abstain |
| Pacific Life | 0 | 0 | 10,736 | 0 | Abstain |
| Global X | 9,458 | 0 | 0 | 0 | For |
| AQR | 0 | 0 | 8,956 | 0 | Abstain |
| Voya | 0 | 0 | 8,755 | 0 | Abstain |
| American Century | 0 | 0 | 7,925 | 0 | Abstain |
| ETFis Series Trust I | 0 | 0 | 6,566 | 0 | Abstain |
| Principal Exchange-Traded Funds | 0 | 0 | 5,546 | 0 | Abstain |
| Principal | 90 | 0 | 2,935 | 0 | Abstain |
| AIG/SunAmerica | 0 | 0 | 2,963 | 0 | Abstain |
| Calvert | 0 | 0 | 2,790 | 0 | Abstain |
| State Street | 2,083 | 0 | 0 | 0 | For |
Showing the 25 largest of 42 asset managers. See all 42 in the interactive database.
Combines 3 wordings of this item as funds reported it.
80% Majority: yes · of votes cast
ALX ONCOLOGY HOLDINGS INC.’s own tally for this item (“Elect Director: Jason Lettmann”): 33,828,276 for, 8,563,708 withheld, per its Form 8-K filed 2024-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 52,100,107 outstanding shares: 65% for, 16% withheld (81% of the company cast a for/withheld vote).
The 42 asset managers below cast 100% of the shares they voted on this item FOR (1,977,955 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 317,526 | 0 | 6,732,159 | 0 | Abstain |
| Vanguard | 936,245 | 0 | 0 | 0 | For |
| BlackRock | 262,973 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 121,933 | 0 | Abstain |
| Charles Schwab | 113,684 | 0 | 0 | 0 | For |
| Aberdeen | 66,211 | 0 | 0 | 0 | For |
| Federated Hermes | 57,913 | 0 | 0 | 0 | For |
| Equitable | 43,519 | 0 | 480 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 43,344 | 0 | 0 | 0 | For |
| John Hancock | 6,656 | 0 | 22,469 | 0 | Abstain |
| Lincoln Financial | 28,155 | 0 | 0 | 0 | For |
| Northern Trust | 19,883 | 0 | 0 | 0 | For |
| Goldman Sachs | 13,815 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 11,377 | 0 | 0 | 0 | For |
| Pacific Life | 10,736 | 0 | 0 | 0 | For |
| Global X | 9,458 | 0 | 0 | 0 | For |
| AQR | 8,956 | 0 | 0 | 0 | For |
| Voya | 0 | 0 | 8,755 | 0 | Abstain |
| American Century | 0 | 0 | 7,925 | 0 | Abstain |
| ETFis Series Trust I | 6,566 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 5,546 | 0 | 0 | 0 | For |
| Principal | 3,025 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 2,963 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 2,790 | 0 | Abstain |
| State Street | 2,083 | 0 | 0 | 0 | For |
Showing the 25 largest of 42 asset managers. See all 42 in the interactive database.
Combines 4 wordings of this item as funds reported it.
68% Majority: yes · of votes cast
ALX ONCOLOGY HOLDINGS INC.’s own tally for this item (“Elect Director: Sophia Randolph, Ph.D.”): 28,671,086 for, 13,720,898 withheld, per its Form 8-K filed 2024-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 52,100,107 outstanding shares: 55% for, 26% withheld (81% of the company cast a for/withheld vote).
The 42 asset managers below cast 100% of the shares they voted on this item FOR (1,800,938 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 317,526 | 0 | 6,732,159 | 0 | Abstain |
| Vanguard | 936,245 | 0 | 0 | 0 | For |
| BlackRock | 262,973 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 121,933 | 0 | Abstain |
| Charles Schwab | 0 | 0 | 113,684 | 0 | Abstain |
| Aberdeen | 66,211 | 0 | 0 | 0 | For |
| Federated Hermes | 57,913 | 0 | 0 | 0 | For |
| Equitable | 4,729 | 0 | 39,270 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 43,344 | 0 | 0 | 0 | For |
| John Hancock | 6,656 | 0 | 22,469 | 0 | Abstain |
| Lincoln Financial | 9,955 | 0 | 18,200 | 0 | Abstain |
| Northern Trust | 19,883 | 0 | 0 | 0 | For |
| Goldman Sachs | 13,815 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 11,377 | 0 | 0 | 0 | For |
| Pacific Life | 10,736 | 0 | 0 | 0 | For |
| Global X | 0 | 0 | 9,458 | 0 | Abstain |
| AQR | 8,956 | 0 | 0 | 0 | For |
| Voya | 8,755 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 7,925 | 0 | Abstain |
| ETFis Series Trust I | 6,566 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 5,546 | 0 | 0 | 0 | For |
| Principal | 3,025 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 2,963 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 2,790 | 0 | Abstain |
| State Street | 0 | 0 | 2,083 | 0 | Abstain |
Showing the 25 largest of 42 asset managers. See all 42 in the interactive database.
Ranked by the number of ALX ONCOLOGY HOLDINGS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 52,100,107 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 26.59% |
| 2 | venBio Partners LLC | 18.62% |
| 3 | Redmile Group, LLC | 8.30% |
| 4 | Vivo Capital, LLC | 8.10% |
| 5 | Vestal Point Capital, LP | 6.58% |
| 6 | Cormorant Asset Management, LP | 4.40% |
| 7 | ORBIMED ADVISORS LLC | 3.04% |
| 8 | MPM BioImpact LLC | 2.45% |
| 9 | Vanguard | 1.86% |
| 10 | BlackRock | 1.73% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Vanguard Group | 2.93% | 13F |
| Lightstone Ventures, L.P. | 2.62% | 13D |
| Citadel Advisors | 2.40% | 13F |
| Geode Capital | 1.16% | 13F |
| State Street | 1.06% | 13F |
| BlackRock | 0.86% | 13F |
| Northern Trust | 0.47% | 13F |
| Renaissance Technologies | 0.45% | 13F |
| T. Rowe Price | 0.45% | 13F |
| Charles Schwab | 0.40% | 13F |
Percentages above are of 52,100,107 shares outstanding, as reported by ALX ONCOLOGY HOLDINGS INC. on its Form 10-Q dated 2024-05-02 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ALX ONCOLOGY HOLDINGS INC.’s 10-Q dated 2024-05-02. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At ALX ONCOLOGY HOLDINGS INC.'s shareholder meeting held 2024-06-12, in the 2023-2024 proxy season, 130 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 843 separate fund positions. On the most widely held item on that ballot — Advisory vote to approve named executive officer compensation. — FOR was 97% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: ALX ONCOLOGY HOLDINGS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-06-17.
ALX ONCOLOGY HOLDINGS INC. proxy season coverage: 2023-2024 (this page).